Premedication to Reduce Amivantamab Associated Infusion Related Reactions

NCT05663866 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Dexamethasone
DRUG: Montelukast
DRUG: Methotrexate
DRUG: Amivantamab
DRUG: Lazertinib

Sponsor

Janssen Research & Development, LLC